Benzinga | Feb 16, 2021 04:07PM EST

Exact Sciences Q4 EPS $(2.79) May Not Compare To $(0.22) Estimate, Sales $466.30M Beat $446.22M Estimate

Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(2.79) per share which missed the analyst consensus estimate of $(0.22) by 1168.18 percent. This is a 654.05 percent decrease over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $466.30 million which beat the analyst consensus estimate of $446.22 million by 4.50 percent. This is a 57.76 percent increase over sales of $295.57 million the same period last year.